How China’s Immense Data Resources Will Impact The Future Of Life Sciences

How China’s Immense Data Resources Will Impact The Future Of Life Sciences

China is slowly tightening its grip on one of its most valuable resources: health data. On July 3, China’s National People’s Congress of China published a draft Data Security Law, that represents a shift in the country’s data strategy. According to the National Information Center, China will pursue “asymmetric advantages in this new round of … Read more

Why The U.S. Will Be Forced To Remove China From Its Domestic Bio-Tech Stack

Why The U.S. Will Be Forced To Remove China From Its Domestic Bio-Tech Stack

Recent face offs at the Sino-Indian border are part of a long-term, low-grade military conflict over a border dispute. What’s different this time is India’s response. Rather than escalate militarily, the Indian government chose to express its sovereignty by banning Chinese apps from India. This is an economic response, and one remedy that is not … Read more

China’s Biotech Ambitions Requires Protecting U.S. Personal Health Data As A National Security Matter

China’s Biotech Ambitions Requires Protecting U.S. Personal Health Data As A National Security Matter

The U.S. government is concerned that domestic personal and health data are at risk for improper or illegal acquisition by the Chinese government and companies related to the Chinese Communist Party (CCP), according to reports by the United States-China Economic and Security Review Commission. Such risks rise to the national security level because China’s access … Read more

A Look At China’s National Innovation Strategy In Relation To The Biotechnology Sector

A Look At China’s National Innovation Strategy In Relation To The Biotechnology Sector

According to a report by the World Bank, China is well advanced in building a national innovation system (NIS) capable of supplying the innovation and technologies needed for a growing economy that is productivity-led. Currently, the country’s NIS focuses on discovering new innovations and accelerating the diffusion of technologies throughout to support a rapidly increasing … Read more

Chinese Biotech BeiGene Raises Largest-Ever Follow-On Offering

Chinese Biotech BeiGene Raises Largest-Ever Follow-On Offering

BeiGene was founded nearly ten years ago in China. Today, the company a lot more than a cute-sounding name. It is a commercial-stage, publicly-traded biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer. The Chinese biotech giant raised $2 billion in a registered direct offering in July. … Read more

Here Are Two ETFs Offering Exposure To Biotech In China

Here Are Two ETFs Offering Exposure To Biotech In China

According to Loncar Funds, biotechnology innovation matters. Whether it is a cure for hepatitis C, new advances in cancer care, or progress against rare and debilitating diseases like cystic fibrosis, patients around the world are benefiting from unprecedented innovation that the biotech industry is delivering. Loncar Funds attributes this innovation to precision medicine. As the … Read more

Progress In Liquid Biopsy Cancer Screening Yields Potential Competition Between China And The U.S.

Progress In Liquid Biopsy Cancer Screening Yields Potential Competition Between China And The U.S.

Two research teams recently reported results from studies involving the long-term evaluation of non-invasive DNA fragments in blood. Evaluating these DNA fragments is called liquid biopsy, and this type of biopsy could vastly improve outcomes through early detection and low false positive rates for a wide variety of cancers. One result is Chinese and the … Read more